| |
|
| |
Founder and Investor Education and Discussion Towards Decision for Funded Data-Analytics, Vertical-Applied AI Companies Considering Efficient International Expansion.
EVENT DESCRIPTION
AI is dramatically reducing the cost of transferring technology, knowledge and specialized business capabilities across borders. Does this mean funded startups should begin expanding internationally earlierand can they do so without diverting substantial capital and management attention from their core business?
This interactive Founder Decision Lab brings together startup CEOs, investors and experienced cross-border operators to examine when a company is genuinely ready to go global and which expansion method offers the best combination of speed, control, capital efficiency and execution risk.
The discussion will begin with first principles:
- Which company capabilities can now be efficiently transferred using AI?
- What still requires local leadership, customer relationships, data, regulatory knowledge and capital?
- And when is a foreign subsidiary, licensing arrangement, joint venture or separately funded local company the right structure?
Participants will examine several active international-expansion initiatives from opposite sides of the model. Committed to participate:
VideoReach AI will discuss the Parent Cmpany decisionwhy international expansion is strategically attractive, which capabilities can transfer, what partnering business arrangements provide efficient leverage, and what risks or distractions the US company wants to avoid.
Jureva will discuss the Clone Company perspective what must be localized, how a locally operated company is built and how technology, capital and in-market execution can be aligned.
Experienced immigrant and cross-border technology CEOs will provide an independent reality check, sharing what they underestimated, what consumed unexpected capital and what they would structure differently today.
The program will culminate in a live International Expansion Clinic. A selected volunteer attendee company will be evaluated against critical questions:
Is the underlying business easily international?
Does your international market present strong opportunity?
Is the companys technology or data advantage market transferable?
Do present commercial and Go-To-Market motion significantly change?
What must be adjusted to perform?
What leadership and investments are required?
Which expansion structure offers the best risk-adjusted outcome?
Is there an efficiently determined realistic execution plan?
FOR FOUNDERS AND CEOs
This session is designed for leaders of funded data, analytics, enterprise-software, vertical-software and AI-enabled companies who want to determine whether international expansion should become part of their next stage of growth.
Founders may apply to have their company considered for the live International Expansion Clinic or request a private International Expansion Readiness Assessment following the event.
FOR INVESTORS
Venture investors, corporate investors, family offices and cross-border investment groups are invited to participate in the discussion and identify portfolio companies whose technology, proprietary data or vertical expertise may be capable of creating substantial value in international markets.
Investors are encouraged to nominate or introduce relevant portfolio-company CEOs to attend the event. Globiant is especially interested in meeting funded companies with proven US technology, early customer validation and with strong potential applicability in the Brazilian market - where Globiant has deep operational experience.
SPONSOR AND PARTICIPANTS: <several in process of commitment>
GLOBIANT works with successful data, analytics, vertical-software and AI companies to evaluate and execute international expansion. Its "Cloning" model combines proven "Parent" Company technology with locally aligned leadership, capital, market knowledge and go-to-market executionallowing the ParentCo to participate in international value creation without assuming the full cost and operational burden of building a foreign business alone.
VIDEOREACH (by Healthipeople) works with hospitals, ambulatory surgery centers, clinics, and other healthcare organizations to improve patient understanding and follow-through across care journeys. Its Digital Clinician Presence model combines provider-approved protocols with AI-generated clinician videos, personalized conversational support, and journey-aware deliveryallowing care teams to extend their trusted presence into patients homes without assuming the cost and operational burden of providing the same guidance manually to every patient.
JUREVA AI - delivers legal case intelligence to vertical specialized law firms whose success depends on case outcomes. Unlike other corporate legal AI often valued for research or process tasks, Jureva strategically reasons across the complete caseincluding facts, evidence, law, risks, judge-jury, and many strategic alternatives. Jureva is anchored by Sanscritic, an advanced fully data secured reasoning layer built to analyze complex, multidimensional matters while keeping lawyers in control - no 3rd party data, IP loss. By connecting case strategy with firm-level operational and financial considerations, Jureva transforms fragmented information into actionable opportunity growth intelligence. This combination uniquely positions Jureva to serve underserved independent plaintiff and contingency-fee law firms contest larger corporate legal IA. Start with free case "bullet-proofing" reasoning today.
FORMAT
Moderated International expansion issues discussion, two active case studies, cross-border CEO perspectives, live company expansion cases and curated networking.
IDEAL ATTENDEES
Founders and CEOs of funded data, analytics, vertical-software and AI companies
Venture capital and private-market investors
Corporate and strategic investors
Cross-border technology founders and operators
International market, regulatory and go-to-market leaders
KEY TAKEAWAY
The question is no longer simply whether your company can sell internationally. The question is whether AI and a systemic process has made your core advantage transferableand whether the right local structure can turn that advantage into a valuable new international business.
The AI era will no longer tolerate dumb un-intentional risky international expansion.
This event is a part of #SFTechWeeka week of events hosted by VCs and startups to bring together the tech ecosystem. Learn more at www.tech-week.com." data-next-head="
|
|
|
|
|
|
|
|
